What is the most appropriate next step in managing a 35-year-old woman with recurrent pregnancy loss, a history of three first-trimester spontaneous abortions, and a 2-cm submucosal fibroid at the uterine fundus, with normal Thyroid-Stimulating Hormone (TSH) levels, negative Lupus Anticoagulant and Antiphospholipid (cardiolipin) antibody tests, and a normal 46,XX karyotype?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The most appropriate next step in management of this patient's recurrent pregnancy loss is to perform a hysteroscopic resection of the submucosal fibroid. This 35-year-old woman has experienced three first-trimester spontaneous abortions within the past year, and her evaluation has revealed a 2-cm submucosal fibroid at the uterine fundus. Submucosal fibroids can distort the uterine cavity and interfere with embryo implantation or early placentation, potentially leading to recurrent pregnancy loss, as supported by a study published in 2000 1. The patient's other evaluation results, including thyroid function, antiphospholipid antibodies, lupus anticoagulant, and karyotype, are all normal, suggesting that the fibroid may be the underlying cause of her recurrent miscarriages. Hysteroscopic resection is a minimally invasive procedure that can be performed as an outpatient surgery with relatively quick recovery time. Following the procedure, the patient should wait approximately 2-3 months before attempting conception again to allow for complete healing of the endometrium. This approach addresses the anatomical factor that may be contributing to her pregnancy losses and offers the best chance for a successful future pregnancy. Some studies have suggested that other treatments, such as uterine artery embolization (UAE), may also be effective in managing uterine fibroids, but the evidence for their use in patients with recurrent pregnancy loss is less clear, as noted in a 2024 study 1. Additionally, medical management options, such as hormonal therapies, may be considered for patients with symptomatic fibroids, but they are not directly applicable to this patient's situation, as discussed in another 2024 study 1. Therefore, based on the available evidence, hysteroscopic resection of the submucosal fibroid is the most appropriate next step in management of this patient's recurrent pregnancy loss. Key points to consider in this patient's management include:

  • The presence of a submucosal fibroid, which is a known risk factor for recurrent pregnancy loss
  • The patient's history of three first-trimester spontaneous abortions, which suggests a possible underlying anatomical cause
  • The need for a minimally invasive procedure that can be performed as an outpatient surgery with relatively quick recovery time
  • The importance of allowing for complete healing of the endometrium before attempting conception again.

From the Research

Recurrent Pregnancy Loss Management

The patient's history of recurrent pregnancy loss, combined with the presence of a 2-cm submucosal fibroid at the uterine fundus, suggests that the fibroid may be a contributing factor to her pregnancy losses.

  • The patient's laboratory results, including a normal TSH level and negative results for lupus anticoagulant and antiphospholipid antibody, help to rule out other potential causes of recurrent pregnancy loss 2, 3.
  • The presence of a submucosal fibroid, which can interfere with implantation and increase the risk of miscarriage, is a significant finding in this case 4.
  • Given the patient's history and the presence of the submucosal fibroid, the most appropriate next step in management would be to consider surgical removal of the fibroid, such as hysteroscopic myomectomy, to improve her chances of carrying a pregnancy to full term 5, 4.
  • It is essential to note that recurrent pregnancy loss is a complex condition, and a thorough evaluation and management approach should be taken to address the patient's specific needs and circumstances 2, 6.

Considerations for Surgical Intervention

  • The patient's overall health, including her normal vital signs and lack of chronic medical conditions, suggests that she is a good candidate for surgical intervention 2.
  • The use of hysteroscopic myomectomy, which has been shown to be a safe and effective procedure for removing submucosal fibroids, may be an appropriate treatment option for this patient 4.
  • The potential benefits of surgical intervention, including improved fertility outcomes and reduced risk of miscarriage, should be carefully weighed against the potential risks and complications of the procedure 5, 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

ACOG practice bulletin. Management of recurrent pregnancy loss. Number 24, February 2001. (Replaces Technical Bulletin Number 212, September 1995). American College of Obstetricians and Gynecologists.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2002

Research

Surgical techniques and outcome in the management of submucous fibroids.

Current opinion in obstetrics & gynecology, 2013

Research

Recurrent pregnancy loss: evaluation and treatment.

Obstetrics and gynecology clinics of North America, 2015

Related Questions

What is the management approach for recurrent pregnancy loss?
What are the causes of recurrent pregnancy loss (RPL)?
What is the treatment for a 6-week pregnant patient with a history of recurrent pregnancy loss and a prolonged partial thromboplastin time (PTT) > 200 seconds due to elevated lactate levels?
What is the recommended lab workup and treatment for a woman experiencing back-to-back early miscarriages?
What dose of estrogen should be prescribed for a 3-week period to build the endometrium in a 31-year-old woman with a history of recurrent pregnancy loss and stage 4 endometriosis, who has undergone excision surgery and is being treated with Lupron (leuprolide) and letrozole (an aromatase inhibitor) 5mg for 90 days, and has 8 PGT (preimplantation genetic testing)-tested normal embryos?
What is the treatment of choice for hepatitis B (HBV) in pregnancy?
What assistive device is most suitable for an elderly patient with diabetic neuropathy and osteoarthritis of the knees?
What lifestyle modifications are recommended for Gastroesophageal Reflux Disease (GERD) management?
What is the most likely cause of anemia in a 72-year-old male with a history of hypertension and chronic atrial fibrillation (a fib), presenting with normocytic anemia and a hemoglobin level of 11.1 g/dL, mean corpuscular volume (MCV) of 104 fL, and normal peripheral smear, vitamin B12 level of 512 pg/mL?
What is the best next step in managing a 22-year-old woman with a simple 4-cm left ovarian cyst, normal Doppler flow, and mild left lower abdominal pain, who uses a copper-containing Intrauterine Device (IUD) for contraception and has a negative urine pregnancy test?
What is the pathophysiology of Gastroesophageal Reflux Disease (GERD)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.